Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Evolent Health Inc(EVH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for EVH
10/23/2026: EVH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Evolent Health is a mid-cap healthcare technology and services firm that helps providers and payers manage high-cost specialty care. The company has a leading position in managing complex conditions like oncology and cardiology through its technology-enabled platform. Its primary growth story is the scalable adoption of value-based care across the U.S. healthcare system, bolstered by strategic acquisitions in AI and clinical services. However, it faces significant risks from competition by large, integrated health insurers and the execution challenges of integrating various business lines. Evolent may suit growth-oriented investors looking for exposure to healthcare efficiency, provided they monitor the firm's progress in achieving consistent operating leverage.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Evolent targets a large, growing market in value-based care and has a consistent history of expanding revenue. |
| Momentum investor | Mixed fit | The stock has experienced periods of volatility requiring a positive trend signal for entry. |
| Value investor | Weak fit | The company’s valuation is typically based on growth expectations rather than current earnings multiples. |
| Dividend investor | Weak fit | Evolent does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Weak fit | The stock exhibits high price volatility common with small-to-mid-cap growth tech firms. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Growth stocks in the healthcare sector often react sharply to interest rate changes and growth expectations. |
| Valuation risk | Medium / high | Investors pay a premium for future growth, which can lead to corrections if growth targets are missed. |
| Competition risk | High | Large insurers (e.g., UnitedHealth) are developing competing internal capabilities that could threaten Evolent’s market share. |
| Business quality | Medium | While the platform is sticky, the dependence on contract renewals poses recurring revenue quality risks. |
| Dividend income | Low / none | No capital is returned to shareholders via dividends at this stage of the company's lifecycle. |
| Execution risk | Medium / high | Integrating multiple acquisitions successfully while maintaining core platform performance is operationally complex. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -18.92% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 542.68M USD | Price to earnings Ratio - | 1Y Target Price 5.75 |
Price to earnings Ratio - | 1Y Target Price 5.75 | ||
Volume (30-day avg) 2.2M shares | Beta 1.02 | 52 Weeks Range 2.10 - 7.88 | Updated Date 10/25/2026 |
52 Weeks Range 2.10 - 7.88 | Updated Date 10/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -4.49 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Clinical Solutions | Specialty management services in oncology and cardiology, generating fees per member per month. | This is their core business where they manage specific expensive medical care, helping clients save money while taking a cut of the savings. |
| Performance Suite | Platform and advisory services for value-based care administration. | This involves selling software and consulting services to help healthcare providers switch to value-based payment models. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 18.87 | Enterprise Value 1.62B | Price to Sales(TTM) 0.26 |
Enterprise Value 1.62B | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 0.74 | Enterprise Value to EBITDA 185.35 | Shares Outstanding 113.06M | Shares Floating 94.23M |
Shares Outstanding 113.06M | Shares Floating 94.23M | ||
Percent Insiders 3.1 | Percent Institutions 101.59 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.